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Objectives: Slow flow, no reflow and distal embolization often occur
during angioplasty in STEMI, compromising optimal myocardial reperfusion.
Minimalist Immediate Mechanical Intervention’s (MIMI) is a strategy based
on recanalization in emergency and postponed stenting. The present study
aimed at assessing the safety and feasibility of MIMI in patients with ST
segment elevation myocardial infarction (STEMI) compared to “immediate
stenting” strategy.
Methods: 98 consecutive patients referred for primary angioplasty were
included. Physicians were free to select the reperfusion strategy among MIMI
or immediate stenting but had to justify their choice. In the MIMI subgroup a
second coronary angiography was planned in a delay >24h.
Results: 40 patients underwent “MIMI” and 58 “immediate stenting”
strategy. MIMI strategy was based on thrombus management, including
mechanical management by thromboaspiration (33 patients 82.5%) and phar-
macological management by using AntiGpIIbIIIa (23 patients 62.16%). The
most important factors for selecting this strategy, in the presence of a TIMI 3
flow were: regression of chest pain, regression of ST segment elevation and
presence of an important thrombotic mass. This strategy could be achieved
with a low complication rate compared to direct stenting. Among MIMI’s
patients, 35 underwent a coronary angiogram’s control after a delay of 1 to
131 days. Seven of these patients were medically treated because of a non-
significant stenosis.
Conclusions: This mono-centric study confirms the feasibility and the
safety of MIMI in our hands. This strategy has additional advantages,
allowing for surgery if required or medical treatment when no significant ste-
nosis remained. This study gives a hint to define the place of the MIMI
strategy in the management of STEMI.
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Purpose: Optical coherence tomography (OCT) allows precise analysis of
the unstable coronary artery lesions characteristics. We investigated the feasi-
bility and optimal timing of OCT guided percutaneous coronary intervention
(PCI) for acute coronary syndromes (ACS) treatment.
Methods: This multicenter registry included patients with ACS and a
large thrombus burden on initial coronary angiography. All patients treated
by successful manual thrombectomy were then explored by immediate OCT
(day 0, group 1) or postponed for subsequent analysis, at the discretion of
the operator. The deferred OCT procedures were performed between day 5
to 7 (delayed procedure/ group 2) or 8 to 30 (late procedure /group 3) fol-
lowing initial coronary angiography. The decision of stenting was based on
the presence of a residual culprit stenosis with a minimal lumen area (MLA)
<4 mm2. 
Results: A total of 93 patients (n=31 in each group) were included (mean
age: 53.3±1.4 years, 78% male, 83% STEMI). OCT was feasible in all cases,
with no complication (thrombus migration, coronary artery dissection or per-
foration).
A thrombus adherent to the culprit lesion was identified in 65% of the
cases. This frequency was significantly lower in late OCT group vs. imme-
diate OCT group (32% vs. 74%, p<0.01). Moreover, the culprit lesion stenosis
decreased over time, as witnessed by the higher MLA in group 3 compared to
group 1 (2.42±0.3 mm2 vs. 5.21±0.76 mm2, p<0.01). 
Patients were treated by coronary artery stenting in 61% of the cases. The
stenting rate was significantly lower in patients with late OCT exploration
compared to the ones with immediate OCT analysis (42% vs. 77%,
p<0.001). A total of n=3 major adverse cardiovascular events (death+non
fatal MI+ non fatal stroke+ need for revascularization) were observed during
follow-up.
Conclusion: OCT guided PCI for treatment of patients with ACS is fea-
sible, safe and prevents unnecessary stenting procedures. Although our data
suggest that a deferred analysis could be a relevant approach, the optimal
timing for TD-OCT procedure following ACS has to be confirmed in larger
studies
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Background: Thromboaspiration (TA) during primary percutaneous
intervention (PPCI) is effective in opening the infarct-related artery in
patients with ST-segment elevation myocardial infarction (STEMI), leading
to better reperfusion and improved outcome. However, the effect of positive
macroscopic efficiency of TA remains unknown. We aimed to evaluate the
impact of positive thrombus retrieval during PPCI with manual TA on
infarct size (IS) and microvascular obstruction (MVO) as assessed by contrast-
enhanced magnetic resonance imaging (CE-MRI) in a subset of patients with
STEMI.
Methods: Inclusion criteria were patients aged <75 years, with first
STEMI referred for PPCI within 12 hours of onset of symptoms, infarct-
related artery ≥2.5 mm in diameter, thrombus score ≥3 and no prior history of
coronary disease. All patients underwent TA before stenting and were catego-
rized according to positive or negative TA. Clinical and procedural character-
istics of study population were recorded and CE-MRI was performed at 5 days
and 6-months to evaluate MVO and IS.
Results: 88 patients were enrolled, mean age 55±10 years; 43.1% in
the positive TA group. Main results are presented in the table. Clinical and
procedural characteristics (90-min total ischemic time, ST-segment resolu-
tion, post-procedural TIMI flow grade and post-stenting myocardial blush
grade, and peak troponin) did not differ significantly between groups.
Independent predictors of final IS were: positive TA (OR 0.34, 95%CI
0.03-0.71), MVO (OR 1.75, 95%CI 1.28-0.71) and IS at 5 days (OR 2.06,
95%CI 1.87-3.32).
Conclusion: Positive thrombus retrieval during primary PPCI with manual
TA in STEMI reduces MVO and in the acute phase and at 6 months and repre-
sents a powerful predictor of final infarct size.
Table – Main results
egative TA 
(=50)
Positive TA 
(+38)
p
MVO (%) 7.6±5.1  3.8±3.1 0.003
IS in the acute phase (%) 28.2±20.8  14.9±8.7  0.004
Final IS at 6 months (%)  22.3±19.3  12.0±8.3  0.002
